cause of pneumonia and meningitis in children. There are more than 90 serotypes of pneumococcal polysaccharides (PS) and their prevalence varies regionally. The development of alternative methods to obtain conjugate…
Background: Pneumococcal disease is a leading preventable cause of childhood diseases and deaths globally with many of the deaths occurring in low and middle-income countries. In Uganda, Pneumococcal Conjugate…
Background: Pneumococcal carriage is a prerequisite for invasive and non-invasive infections, where children and elderly are the most vulnerable age groups. Pneumococcal conjugate vaccine PCV7 is available in Jordan…
Background: Influenza and Pneumococcal diseases are major causes of morbidity and Mortality across the globe. Standing orders are great way to increase the compliance rates and reduce missed opportunities ... purpose of…
wide range of diseases mostly in young children and older adults. The heptavalent pneumococcal conjugate vaccine (PCV7) that is composed of seven serotypes ... determine immune responses to PCV7 among Thai children with…
Pneumococcal proteins have been studied as alternative to polysaccharide based vaccines. PspA is one of the most promising vaccine candidates. Several studies showed protection after immunization with N-terminal…
Background & Aim: Data from Phase-I clinical trials showed that protein based pneumococcal vaccines induced poor immune responses. To address this problem the protein needs to be presented ... high level of protection…
Background and Aim: Data from Phase I clinical trials showed that protein based pneumococcal vaccines induced poor immune responses. To address this problem the protein needs to be presented ... high level of protection…
response and for needle-free vaccination. The aim of this study was to adsorb pneumococcal protein (PspA), onto poly(glycerol adipate-co-ω-pentadecalactone), PGA-co-PDL, nanoparticles ... both formulations after…
pneumonia and is therefore considered a serious threat to public health. For these reasons, pneumococcal vaccines have been developed since the 1970s, and two types of pneumococcal vaccines are currently ... available…
recently reported an increased risk of serious pneumococcal disease (SPD) in asthmatics. Little is known about the impact of asthma status on the severity of SPD. We compared the severity ... serious pneumococcal…
Background: We have published several studies related to Invasive Pneumococcal Disease, and effectiveness of Pneumococcal Conjugate Vaccines: 7-valent (PCV7) and 13-valent (PCV13). This is the first Latin American…
Background: Published data on the frequency and distribution of high-risk factors for pneumococcal disease are limited. This study investigated the prevalence of high-risk underlying conditions for pneumococcal disease…
Statement of the Problem: Invasive pneumococcal disease (IPD) caused by Streptococcus pneumoniae remains a global health problem and imposes a great burden on society and health care system ... children under 15 years…
pneumococcus. Few countries in the Aisa-Pacific region have introduced pneumococcal conjugate vaccine (PCV) and there are few data from this region on the direct or indirect effects ... will assess the direct and…
Objective: The 23-valent pneumococcal vaccine is recommended for adults over 65 years of age and younger adults with certain medical conditions. The Centers for Disease Control and Prevention ... state insufficient…
isolates from invasive meningitis cases, to determine the serotypes and susceptibility of serogroups/serotypes. Pneumococcal meningitis isolates were isolated from Cerebrospinal Fluid (CSF), between 2012 and 2013…
Objective: Nasopharyngeal pneumococcal carriage creates a significant risk factor for the spread of resistant strains in society and the occurrence of invasive disease. In this study it was intended ... investigate the…
Background & Aim: Cuba has a new heptavalent conjugate pneumococcal vaccine under advanced clinical development. The introduction in children of 1-5 years old is scheduled in 2018. Estimates of disease ... needed to…
individuals and the elderly fail to demonstrate robust and durable immune responses against pneumococcal polysaccharides. Herein, we assessed altered B cell function in high risk groups by utilizing single cell…
Advisory Committee on Immunization Practices (ACIP) approved a dose of 13-valent pneumococcal conjugate vaccine (PCV13) for all adults at age 65 years. This further complicated the pneumococcal vaccination schedule…
usually begins with nasopharyngeal colonization that may be a significant risk factor for invasive pneumococcal disease. In this study it is aimed to determine the nasopharyngeal pneumococcal carriage rate ... preschool…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.